{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19656", "batch_size": 36, "batch_pos": 33, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment factually reports deal details without using Q2 cues.", "method": "llm_batch", "batch_id": "batch_2_2796", "batch_size": 197, "batch_pos": 194, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "'secures' and 'includes' are not moderate verbs from the list. Scale ('665,000 doses', '40 million vaccines') is not tied to a moderate verb describing virus impact.", "method": "llm_batch", "batch_id": "batch_3_17636", "batch_size": 95, "batch_pos": 92, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_20412", "batch_size": 89, "batch_pos": 86, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports facts about a deal without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17300", "batch_size": 84, "batch_pos": 81, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser token found.", "method": "llm_batch", "batch_id": "batch_6_7056", "batch_size": 20, "batch_pos": 17, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_3168", "batch_size": 193, "batch_pos": 190, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes the deal terms ('secures up to 665,000 doses... includes an option for a further 40 million vaccines') detailing the preparedness measure.", "method": "llm_batch", "batch_id": "batch_8_19136", "batch_size": 148, "batch_pos": 145, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
